Hallett David
SEC insider (Form 3/4/5 filer). CIK 0002006495. Chief Scientific Officer at RECURSION PHARMACEUTICALS, INC. (RXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SALT LAKE CITY, UT.
Companies Hallett David has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Officer, Chief Scientific Officer
Hallett David
CIK: 0002006495
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RECURSION PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect26.7K shares at avg. $3.16$84K - May 15, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect26.7K shares at avg. $3.04$81K - Feb 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect11.9K shares at avg. $3.49$42K - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect502.1K shares- - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect24.3K shares- - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect11.4K shares at avg. $3.98$45K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 26,657 | $3.16 | $84,236 | Direct |
| May 15, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 26,657 | $3.04 | $81,037 | Direct |
| Feb 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 11,908 | $3.49 | $41,559 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 502,064 | - | $0 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 24,254 | - | $0 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 11,400 | $3.98 | $45,372 | Direct |
1-6 of 6 transactions